Jumping DNA May Trigger Cancer Years Before Diagnosis
Long before a tumor is detected, its genome may already be unfolding. By identifying these genomic changes, researchers may be able to detect cancer cells before symptoms begin to appear.
New research published in Science suggests that fragments of “jumping DNA” destabilize the human genome in the early stages of cancer development, remodeling chromosomes years before diagnosis.
These genetic fragments, called LINE-1 (L1) elements, behave like molecular parasites. Once considered background noise in an already chaotic cancer genome, L1s now appear to play a much more active role. By copying and pasting themselves into DNA, they help create the genomic instability that fuels the progression of cancer and gives malignant cells more opportunities to evade treatment.
“Cancer genomes are more influenced by these jumping fragments of DNA parasites than previously thought,” José Tubio, study coordinator, said in a press release.
Learn more: A mysterious virus hidden in a common gut bacteria linked to colorectal cancer
How LINE-1 skipping DNA fuels cancer
L1 elements are ancient genetic “hitchhikers” integrated into the human genome. They are considered parasitic DNA because they exist primarily to replicate through a process called retrotransposition.
“It’s as if two different pages of a book were torn simultaneously and fragments exchanged. The L1 elements behave like glue that sticks the two pages together,” said first author Sonia Zumalave.
It is already known that retrotransposition by L1 is common in cancers such as head and neck, lung and colorectal. Early evidence suggests that these events help tumors adapt by introducing mutations that affect cancer-related genes. But until now, researchers largely viewed L1 activity as a side effect of cancer, not a driving factor.
The new findings challenge this hypothesis. Rather than appearing after cancer genomes collapse, L1 activity appears to push them toward this instability in the first place.
Finding jumping DNA in tumors
To explore the true impact of L1, the researchers performed genome sequencing of ten tumors with unusually high L1 activity. Among these samples, they identified 6,418 retrotransposition events, most of them simple insertions changing the length of the genome.
However, there were also 152 cases in which L1 activity caused large-scale structural rearrangements – dramatic architectural changes in chromosomes that can accelerate cancer development. These events occurred in approximately 1 in 40 tumors with high L1 activity.
“On paper, 152 doesn’t seem like a huge number. But when you look at just ten tumors, it’s extraordinarily high,” explained Bernardo Rodriguez-Martin, one of the lead authors of the study.
How L1 activity could enable early cancer detection
One of the biggest findings of this study concerned timing. Whole genome doubling – a major step in tumor formation – occurred an average of 4.77 years before diagnosis. Most of the observed L1 activity occurred before this event.
This timing positioned L1 retrotranspositions as an early mutational force, not a byproduct of late-stage cancer. It also raised the possibility that tracking L1-induced changes could help detect cancer risk years in advance.
“The next priority should be to understand when and where L1 activity tips the scales and how to target it therapeutically,” Rodriguez-Martin concluded.
If researchers can detect these jumping DNA parasites early, they could discover new avenues toward early diagnosis and prevention, thereby detecting cancer well before symptoms appear.
This article does not offer medical advice and should be used for informational purposes only.
Learn more: Dogs can smell deadly canine cancer, offering new path to earlier detection
Article sources
Our Discovermagazine.com editors use peer-reviewed research and high-quality sources for our articles, and our editors review the articles for scientific accuracy and editorial standards. See the sources used below for this article:
